
We use cookies to offer you the best experience on our site. You can find out more about the cookies we use or disable them in the Cookie settings
The use of Cyclic Olefin Copolymer (COC) for the vial body and a proprietary Thermoplastic Elastomer (TPE) for the stopper ensures materials suitable for cryogenic temperatures with similar low-temperature behaviour
Manufacturing Process: Precise molding and robotic assembly with tight tolerances (±0.02 mm repeatability) ensure optimal fitting of the vial components
Sterilisation by gamma irradiation, combined with the compression between the stopper and vial body, creates a chemical bonding between the COC and TPE. This bonding plays a significant role in maintaining CCI at low temperatures
The vial is filled through the stopper with a sterile needle, which then mechanically recloses. A subsequent one-second laser shot re-seals the needle trace, and a sterile cap is added for protection. This process maintains a functionally closed system throughout filling, minimising contamination risks
Our whitepaper covers the extensive validation efforts that demonstrate the resistance of the AT-Closed Vial® to (ultra) cold temperature storage. These include:
In conclusion, the AT-Closed Vial® technology offers a robust and validated solution for maintaining container closure integrity of cell and gene therapy products during cryogenic storage.
Its unique design, material composition, and manufacturing process, coupled with a closed filling system, address critical challenges in this rapidly evolving field. The extensive validation data supports its suitability for ensuring product quality throughout the lifecycle, making it a preferred choice for numerous sponsors in the cell and gene therapy. The ability to scale the filling process and adapt to different container sizes further enhances its utility for developers .